Demon
Cholesterol
Statins to the Rescue?
Bempedoic Acid: A Newer Useless Cholesterol-Lowering Drug
Pam Popper, PresidentWellness Forum Health
Esperion’s website reports that "once-daily therapy was shown in a clinical trial to deliver" 38% reduction in LDL-C compared to placebo.[1] Keep in mind that this is a change in a surrogate marker – which may not have any relationship to meaningful health improvement.
According to an article published in the New England Journal of Medicine, a randomized controlled clinical trial that included 13,970 patients showed that treatment with bempedoic acid was associated with a lower risk of major cardiovascular events – deaths from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, or coronary revascularization. According to the study, the relative risk reduction for heart attacks in patients taking Nexletol was almost 23%.[2] One could conclude from this overview that this drug is a reasonable alternative to statins and might be even more effective, a good thing since, when used for primary prevention statin drugs reduce the risk of events by less than 2%.
But further analysis, looking at risk reduction in myocardial infarction in absolute terms shows a different picture:
Nexletol group: 261 MI events in 6992 patients 3.7% risk
Placebo: 334 MI events in 6978 patients 4.8% risk
Absolute risk reduction: 1.1% reduction
Relative risk reduction: 22.9% reduction
Some additional information from the Esperion’s website reinforces the uselessness of this drug:
"Limitations of use for both Nexletol and Nexlezet:
"Safety information:
Almost no one would agree to take this drug if shown the actual risk reduction and the side effects. Most people might at least consider adopting a low-fat, plant-centered diet if given data showing the incredible health improvement that results. This lack of real informed consent is one of the reasons why people remain so sick, and why the erroneous perception of the lazy American who does not care about health and just wants to take a pill persists. The pill is falsely represented to be safe and effective, and the diet and lifestyle choice is almost never offered.
Reporting the benefit of drugs, supplements, and medical interventions in relative terms is very misleading, and relative risk reduction should not be the metric used in making treatment decisions.
[1] https://www.nexlizethcp.com/?
[2] Nissen SE, Lincoff AM. Brennan D et al. "Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients." NEJM 2023 Mar; doi: 10.1056/NEJMoa2215024. Online ahead of print